Effectiveness of Prescription-Based CNS Stimulants on Hospitalization in Patients With Schizophrenia: A Nation-Wide Register Study

Vyvanse (Lisdexamfetamine), a product developed by Shire Pharmaceuticals, has shown some positive effects against negative symptoms in a randomized controlled trial (phase 2 I think):